カテゴリー： 世界, 医療/バイオ, LP Information

世界の非滅菌液体市場予測 2023年-2029年

【英語タイトル】Global Non-sterile Liquid Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC11840）・商品コード：LP23DC11840
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の非滅菌液体市場」は、過去の販売実績から2022年の世界の非滅菌液体の総販売量を検討し、2023年から2029年の予測される非滅菌液体の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の非滅菌液体の市場規模を掲載し、XXX百万米ドル規模の世界の非滅菌液体市場の詳細な分析を提供します。本インサイトレポートは、世界の非滅菌液体業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の非滅菌液体市場における各社の独自のポジションをより深く理解するために、非滅菌液体製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の非滅菌液体市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。非滅菌液体の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。非滅菌液体の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。非滅菌液体のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

非滅菌液体の世界主要メーカーとしては、Nycomed、 AbbVie、 Aenova、 APPCO、 Atral Pharmaceutical、 Aurigene Pharmaceutical Services、 Biological E. Ltd.、 BioPlus Life Sciences、 Bora Pharmaceuticals、 Cambrex Corporation、 JGL d.d.、 Mikart、 PharmaVision、 Pierre Fabre、 TriRx Pharmaceutical Services、 UI Pharmaceuticals、 Wasdell Groupなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の非滅菌液体市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では非滅菌液体市場をセグメンテーションし、種類別 (溶液、懸濁液、ゲル、シロップ、エタノール液)、用途別 (ヒト用医薬品、栄養補助食品、化粧品、医療機器)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：溶液、懸濁液、ゲル、シロップ、エタノール液

・用途別区分：ヒト用医薬品、栄養補助食品、化粧品、医療機器

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の非滅菌液体市場の10年間の市場状況・展望は？
・世界および地域別に見た非滅菌液体市場成長の要因は何か？
・非滅菌液体の市場機会はエンドマーケットの規模によってどのように変化するのか？
・非滅菌液体のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：非滅菌液体の年間販売量2018-2029、地域別現状・将来分析
・非滅菌液体の種類別セグメント：溶液、懸濁液、ゲル、シロップ、エタノール液
・非滅菌液体の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・非滅菌液体の用途別セグメント：ヒト用医薬品、栄養補助食品、化粧品、医療機器
・非滅菌液体の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の非滅菌液体市場
・企業別のグローバル非滅菌液体市場データ：2018-2023年の年間販売量、市場シェア
・企業別の非滅菌液体の年間売上：2018-2023年の売上、市場シェア
・企業別の非滅菌液体販売価格
・主要企業の非滅菌液体生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

非滅菌液体の地域別レビュー
・地域別の非滅菌液体市場規模2018-2023：年間販売量、売上
・主要国別の非滅菌液体市場規模2018-2023：年間販売量、売上
・南北アメリカの非滅菌液体販売の成長
・アジア太平洋の非滅菌液体販売の成長
・ヨーロッパの非滅菌液体販売の成長
・中東・アフリカの非滅菌液体販売の成長

南北アメリカ市場
・南北アメリカの国別の非滅菌液体販売量、売上（2018-2023）
・南北アメリカの非滅菌液体の種類別販売量
・南北アメリカの非滅菌液体の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の非滅菌液体販売量、売上（2018-2023）
・アジア太平洋の非滅菌液体の種類別販売量
・アジア太平洋の非滅菌液体の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の非滅菌液体販売量、売上（2018-2023）
・ヨーロッパの非滅菌液体の種類別販売量
・ヨーロッパの非滅菌液体の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の非滅菌液体販売量、売上（2018-2023）
・中東・アフリカの非滅菌液体の種類別販売量
・中東・アフリカの非滅菌液体の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・非滅菌液体の製造コスト構造分析
・非滅菌液体の製造プロセス分析
・非滅菌液体の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・非滅菌液体の主要なグローバル販売業者
・非滅菌液体の主要なグローバル顧客

地域別の非滅菌液体市場予測レビュー
・地域別の非滅菌液体市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・非滅菌液体の種類別市場規模予測
・非滅菌液体の用途別市場規模予測

主要企業分析
Nycomed、 AbbVie、 Aenova、 APPCO、 Atral Pharmaceutical、 Aurigene Pharmaceutical Services、 Biological E. Ltd.、 BioPlus Life Sciences、 Bora Pharmaceuticals、 Cambrex Corporation、 JGL d.d.、 Mikart、 PharmaVision、 Pierre Fabre、 TriRx Pharmaceutical Services、 UI Pharmaceuticals、 Wasdell Group
・企業情報
・非滅菌液体製品
・非滅菌液体販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Non-sterile Liquid market size is projected to grow from US$ 2543.5 million in 2022 to US$ 3881.4 million in 2029; it is expected to grow at a CAGR of 6.2% from 2023 to 2029.
United States market for Non-sterile Liquid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Non-sterile Liquid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Non-sterile Liquid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Non-sterile Liquid players cover Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences and Bora Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Non-sterile liquid can be used to deliver a variety of medications, including prescription drugs, non-prescription drugs, vitamins, dietary supplements, and nutraceuticals.
LPI (LP Information)’ newest research report, the “Non-sterile Liquid Industry Forecast” looks at past sales and reviews total world Non-sterile Liquid sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-sterile Liquid sales for 2023 through 2029. With Non-sterile Liquid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-sterile Liquid industry.
This Insight Report provides a comprehensive analysis of the global Non-sterile Liquid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-sterile Liquid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-sterile Liquid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-sterile Liquid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-sterile Liquid.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-sterile Liquid market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Solution
Suspension
Gel
Syrup
Ethanolic Liquid
Segmentation by application
Human Medication
Nutraceuticals
Cosmetics
Medical Devices
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Nycomed
AbbVie
Aenova
APPCO
Atral Pharmaceutical
Aurigene Pharmaceutical Services
Biological E. Ltd.
BioPlus Life Sciences
Bora Pharmaceuticals
Cambrex Corporation
JGL d.d.
Mikart
PharmaVision
Pierre Fabre
TriRx Pharmaceutical Services
UI Pharmaceuticals
Wasdell Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-sterile Liquid market?
What factors are driving Non-sterile Liquid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-sterile Liquid market opportunities vary by end market size?
How does Non-sterile Liquid break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-sterile Liquid Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Non-sterile Liquid by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Non-sterile Liquid by Country/Region, 2018, 2022 & 2029
2.2 Non-sterile Liquid Segment by Type
2.2.1 Solution
2.2.2 Suspension
2.2.3 Gel
2.2.4 Syrup
2.2.5 Ethanolic Liquid
2.3 Non-sterile Liquid Sales by Type
2.3.1 Global Non-sterile Liquid Sales Market Share by Type (2018-2023)
2.3.2 Global Non-sterile Liquid Revenue and Market Share by Type (2018-2023)
2.3.3 Global Non-sterile Liquid Sale Price by Type (2018-2023)
2.4 Non-sterile Liquid Segment by Application
2.4.1 Human Medication
2.4.2 Nutraceuticals
2.4.3 Cosmetics
2.4.4 Medical Devices
2.5 Non-sterile Liquid Sales by Application
2.5.1 Global Non-sterile Liquid Sale Market Share by Application (2018-2023)
2.5.2 Global Non-sterile Liquid Revenue and Market Share by Application (2018-2023)
2.5.3 Global Non-sterile Liquid Sale Price by Application (2018-2023)
3 Global Non-sterile Liquid by Company
3.1 Global Non-sterile Liquid Breakdown Data by Company
3.1.1 Global Non-sterile Liquid Annual Sales by Company (2018-2023)
3.1.2 Global Non-sterile Liquid Sales Market Share by Company (2018-2023)
3.2 Global Non-sterile Liquid Annual Revenue by Company (2018-2023)
3.2.1 Global Non-sterile Liquid Revenue by Company (2018-2023)
3.2.2 Global Non-sterile Liquid Revenue Market Share by Company (2018-2023)
3.3 Global Non-sterile Liquid Sale Price by Company
3.4 Key Manufacturers Non-sterile Liquid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-sterile Liquid Product Location Distribution
3.4.2 Players Non-sterile Liquid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-sterile Liquid by Geographic Region
4.1 World Historic Non-sterile Liquid Market Size by Geographic Region (2018-2023)
4.1.1 Global Non-sterile Liquid Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Non-sterile Liquid Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-sterile Liquid Market Size by Country/Region (2018-2023)
4.2.1 Global Non-sterile Liquid Annual Sales by Country/Region (2018-2023)
4.2.2 Global Non-sterile Liquid Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-sterile Liquid Sales Growth
4.4 APAC Non-sterile Liquid Sales Growth
4.5 Europe Non-sterile Liquid Sales Growth
4.6 Middle East & Africa Non-sterile Liquid Sales Growth
5 Americas
5.1 Americas Non-sterile Liquid Sales by Country
5.1.1 Americas Non-sterile Liquid Sales by Country (2018-2023)
5.1.2 Americas Non-sterile Liquid Revenue by Country (2018-2023)
5.2 Americas Non-sterile Liquid Sales by Type
5.3 Americas Non-sterile Liquid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-sterile Liquid Sales by Region
6.1.1 APAC Non-sterile Liquid Sales by Region (2018-2023)
6.1.2 APAC Non-sterile Liquid Revenue by Region (2018-2023)
6.2 APAC Non-sterile Liquid Sales by Type
6.3 APAC Non-sterile Liquid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-sterile Liquid by Country
7.1.1 Europe Non-sterile Liquid Sales by Country (2018-2023)
7.1.2 Europe Non-sterile Liquid Revenue by Country (2018-2023)
7.2 Europe Non-sterile Liquid Sales by Type
7.3 Europe Non-sterile Liquid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-sterile Liquid by Country
8.1.1 Middle East & Africa Non-sterile Liquid Sales by Country (2018-2023)
8.1.2 Middle East & Africa Non-sterile Liquid Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-sterile Liquid Sales by Type
8.3 Middle East & Africa Non-sterile Liquid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-sterile Liquid
10.3 Manufacturing Process Analysis of Non-sterile Liquid
10.4 Industry Chain Structure of Non-sterile Liquid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-sterile Liquid Distributors
11.3 Non-sterile Liquid Customer
12 World Forecast Review for Non-sterile Liquid by Geographic Region
12.1 Global Non-sterile Liquid Market Size Forecast by Region
12.1.1 Global Non-sterile Liquid Forecast by Region (2024-2029)
12.1.2 Global Non-sterile Liquid Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-sterile Liquid Forecast by Type
12.7 Global Non-sterile Liquid Forecast by Application
13 Key Players Analysis
13.1 Nycomed
13.1.1 Nycomed Company Information
13.1.2 Nycomed Non-sterile Liquid Product Portfolios and Specifications
13.1.3 Nycomed Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Nycomed Main Business Overview
13.1.5 Nycomed Latest Developments
13.2 AbbVie
13.2.1 AbbVie Company Information
13.2.2 AbbVie Non-sterile Liquid Product Portfolios and Specifications
13.2.3 AbbVie Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 AbbVie Main Business Overview
13.2.5 AbbVie Latest Developments
13.3 Aenova
13.3.1 Aenova Company Information
13.3.2 Aenova Non-sterile Liquid Product Portfolios and Specifications
13.3.3 Aenova Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Aenova Main Business Overview
13.3.5 Aenova Latest Developments
13.4 APPCO
13.4.1 APPCO Company Information
13.4.2 APPCO Non-sterile Liquid Product Portfolios and Specifications
13.4.3 APPCO Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 APPCO Main Business Overview
13.4.5 APPCO Latest Developments
13.5 Atral Pharmaceutical
13.5.1 Atral Pharmaceutical Company Information
13.5.2 Atral Pharmaceutical Non-sterile Liquid Product Portfolios and Specifications
13.5.3 Atral Pharmaceutical Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Atral Pharmaceutical Main Business Overview
13.5.5 Atral Pharmaceutical Latest Developments
13.6 Aurigene Pharmaceutical Services
13.6.1 Aurigene Pharmaceutical Services Company Information
13.6.2 Aurigene Pharmaceutical Services Non-sterile Liquid Product Portfolios and Specifications
13.6.3 Aurigene Pharmaceutical Services Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Aurigene Pharmaceutical Services Main Business Overview
13.6.5 Aurigene Pharmaceutical Services Latest Developments
13.7 Biological E. Ltd.
13.7.1 Biological E. Ltd. Company Information
13.7.2 Biological E. Ltd. Non-sterile Liquid Product Portfolios and Specifications
13.7.3 Biological E. Ltd. Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biological E. Ltd. Main Business Overview
13.7.5 Biological E. Ltd. Latest Developments
13.8 BioPlus Life Sciences
13.8.1 BioPlus Life Sciences Company Information
13.8.2 BioPlus Life Sciences Non-sterile Liquid Product Portfolios and Specifications
13.8.3 BioPlus Life Sciences Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 BioPlus Life Sciences Main Business Overview
13.8.5 BioPlus Life Sciences Latest Developments
13.9 Bora Pharmaceuticals
13.9.1 Bora Pharmaceuticals Company Information
13.9.2 Bora Pharmaceuticals Non-sterile Liquid Product Portfolios and Specifications
13.9.3 Bora Pharmaceuticals Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bora Pharmaceuticals Main Business Overview
13.9.5 Bora Pharmaceuticals Latest Developments
13.10 Cambrex Corporation
13.10.1 Cambrex Corporation Company Information
13.10.2 Cambrex Corporation Non-sterile Liquid Product Portfolios and Specifications
13.10.3 Cambrex Corporation Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Cambrex Corporation Main Business Overview
13.10.5 Cambrex Corporation Latest Developments
13.11 JGL d.d.
13.11.1 JGL d.d. Company Information
13.11.2 JGL d.d. Non-sterile Liquid Product Portfolios and Specifications
13.11.3 JGL d.d. Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 JGL d.d. Main Business Overview
13.11.5 JGL d.d. Latest Developments
13.12 Mikart
13.12.1 Mikart Company Information
13.12.2 Mikart Non-sterile Liquid Product Portfolios and Specifications
13.12.3 Mikart Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Mikart Main Business Overview
13.12.5 Mikart Latest Developments
13.13 PharmaVision
13.13.1 PharmaVision Company Information
13.13.2 PharmaVision Non-sterile Liquid Product Portfolios and Specifications
13.13.3 PharmaVision Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 PharmaVision Main Business Overview
13.13.5 PharmaVision Latest Developments
13.14 Pierre Fabre
13.14.1 Pierre Fabre Company Information
13.14.2 Pierre Fabre Non-sterile Liquid Product Portfolios and Specifications
13.14.3 Pierre Fabre Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Pierre Fabre Main Business Overview
13.14.5 Pierre Fabre Latest Developments
13.15 TriRx Pharmaceutical Services
13.15.1 TriRx Pharmaceutical Services Company Information
13.15.2 TriRx Pharmaceutical Services Non-sterile Liquid Product Portfolios and Specifications
13.15.3 TriRx Pharmaceutical Services Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 TriRx Pharmaceutical Services Main Business Overview
13.15.5 TriRx Pharmaceutical Services Latest Developments
13.16 UI Pharmaceuticals
13.16.1 UI Pharmaceuticals Company Information
13.16.2 UI Pharmaceuticals Non-sterile Liquid Product Portfolios and Specifications
13.16.3 UI Pharmaceuticals Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 UI Pharmaceuticals Main Business Overview
13.16.5 UI Pharmaceuticals Latest Developments
13.17 Wasdell Group
13.17.1 Wasdell Group Company Information
13.17.2 Wasdell Group Non-sterile Liquid Product Portfolios and Specifications
13.17.3 Wasdell Group Non-sterile Liquid Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Wasdell Group Main Business Overview
13.17.5 Wasdell Group Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Non-sterile Liquid Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-sterile Liquid Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players of Suspension
Table 5. Major Players of Gel
Table 6. Major Players of Syrup
Table 7. Major Players of Ethanolic Liquid
Table 8. Global Non-sterile Liquid Sales by Type (2018-2023) & (K Units)
Table 9. Global Non-sterile Liquid Sales Market Share by Type (2018-2023)
Table 10. Global Non-sterile Liquid Revenue by Type (2018-2023) & ($ million)
Table 11. Global Non-sterile Liquid Revenue Market Share by Type (2018-2023)
Table 12. Global Non-sterile Liquid Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Non-sterile Liquid Sales by Application (2018-2023) & (K Units)
Table 14. Global Non-sterile Liquid Sales Market Share by Application (2018-2023)
Table 15. Global Non-sterile Liquid Revenue by Application (2018-2023)
Table 16. Global Non-sterile Liquid Revenue Market Share by Application (2018-2023)
Table 17. Global Non-sterile Liquid Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Non-sterile Liquid Sales by Company (2018-2023) & (K Units)
Table 19. Global Non-sterile Liquid Sales Market Share by Company (2018-2023)
Table 20. Global Non-sterile Liquid Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Non-sterile Liquid Revenue Market Share by Company (2018-2023)
Table 22. Global Non-sterile Liquid Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Non-sterile Liquid Producing Area Distribution and Sales Area
Table 24. Players Non-sterile Liquid Products Offered
Table 25. Non-sterile Liquid Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Non-sterile Liquid Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Non-sterile Liquid Sales Market Share Geographic Region (2018-2023)
Table 30. Global Non-sterile Liquid Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Non-sterile Liquid Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Non-sterile Liquid Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Non-sterile Liquid Sales Market Share by Country/Region (2018-2023)
Table 34. Global Non-sterile Liquid Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Non-sterile Liquid Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Non-sterile Liquid Sales by Country (2018-2023) & (K Units)
Table 37. Americas Non-sterile Liquid Sales Market Share by Country (2018-2023)
Table 38. Americas Non-sterile Liquid Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Non-sterile Liquid Revenue Market Share by Country (2018-2023)
Table 40. Americas Non-sterile Liquid Sales by Type (2018-2023) & (K Units)
Table 41. Americas Non-sterile Liquid Sales by Application (2018-2023) & (K Units)
Table 42. APAC Non-sterile Liquid Sales by Region (2018-2023) & (K Units)
Table 43. APAC Non-sterile Liquid Sales Market Share by Region (2018-2023)
Table 44. APAC Non-sterile Liquid Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Non-sterile Liquid Revenue Market Share by Region (2018-2023)
Table 46. APAC Non-sterile Liquid Sales by Type (2018-2023) & (K Units)
Table 47. APAC Non-sterile Liquid Sales by Application (2018-2023) & (K Units)
Table 48. Europe Non-sterile Liquid Sales by Country (2018-2023) & (K Units)
Table 49. Europe Non-sterile Liquid Sales Market Share by Country (2018-2023)
Table 50. Europe Non-sterile Liquid Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Non-sterile Liquid Revenue Market Share by Country (2018-2023)
Table 52. Europe Non-sterile Liquid Sales by Type (2018-2023) & (K Units)
Table 53. Europe Non-sterile Liquid Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Non-sterile Liquid Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Non-sterile Liquid Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Non-sterile Liquid Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Non-sterile Liquid Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Non-sterile Liquid Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Non-sterile Liquid Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Non-sterile Liquid
Table 61. Key Market Challenges & Risks of Non-sterile Liquid
Table 62. Key Industry Trends of Non-sterile Liquid
Table 63. Non-sterile Liquid Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Non-sterile Liquid Distributors List
Table 66. Non-sterile Liquid Customer List
Table 67. Global Non-sterile Liquid Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Non-sterile Liquid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Non-sterile Liquid Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Non-sterile Liquid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Non-sterile Liquid Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Non-sterile Liquid Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Non-sterile Liquid Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Non-sterile Liquid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Non-sterile Liquid Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Non-sterile Liquid Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Non-sterile Liquid Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Non-sterile Liquid Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Non-sterile Liquid Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Non-sterile Liquid Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Nycomed Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 82. Nycomed Non-sterile Liquid Product Portfolios and Specifications
Table 83. Nycomed Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Nycomed Main Business
Table 85. Nycomed Latest Developments
Table 86. AbbVie Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 87. AbbVie Non-sterile Liquid Product Portfolios and Specifications
Table 88. AbbVie Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. AbbVie Main Business
Table 90. AbbVie Latest Developments
Table 91. Aenova Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 92. Aenova Non-sterile Liquid Product Portfolios and Specifications
Table 93. Aenova Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Aenova Main Business
Table 95. Aenova Latest Developments
Table 96. APPCO Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 97. APPCO Non-sterile Liquid Product Portfolios and Specifications
Table 98. APPCO Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. APPCO Main Business
Table 100. APPCO Latest Developments
Table 101. Atral Pharmaceutical Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 102. Atral Pharmaceutical Non-sterile Liquid Product Portfolios and Specifications
Table 103. Atral Pharmaceutical Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Atral Pharmaceutical Main Business
Table 105. Atral Pharmaceutical Latest Developments
Table 106. Aurigene Pharmaceutical Services Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 107. Aurigene Pharmaceutical Services Non-sterile Liquid Product Portfolios and Specifications
Table 108. Aurigene Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Aurigene Pharmaceutical Services Main Business
Table 110. Aurigene Pharmaceutical Services Latest Developments
Table 111. Biological E. Ltd. Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 112. Biological E. Ltd. Non-sterile Liquid Product Portfolios and Specifications
Table 113. Biological E. Ltd. Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. Biological E. Ltd. Main Business
Table 115. Biological E. Ltd. Latest Developments
Table 116. BioPlus Life Sciences Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 117. BioPlus Life Sciences Non-sterile Liquid Product Portfolios and Specifications
Table 118. BioPlus Life Sciences Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. BioPlus Life Sciences Main Business
Table 120. BioPlus Life Sciences Latest Developments
Table 121. Bora Pharmaceuticals Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 122. Bora Pharmaceuticals Non-sterile Liquid Product Portfolios and Specifications
Table 123. Bora Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. Bora Pharmaceuticals Main Business
Table 125. Bora Pharmaceuticals Latest Developments
Table 126. Cambrex Corporation Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 127. Cambrex Corporation Non-sterile Liquid Product Portfolios and Specifications
Table 128. Cambrex Corporation Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Cambrex Corporation Main Business
Table 130. Cambrex Corporation Latest Developments
Table 131. JGL d.d. Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 132. JGL d.d. Non-sterile Liquid Product Portfolios and Specifications
Table 133. JGL d.d. Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. JGL d.d. Main Business
Table 135. JGL d.d. Latest Developments
Table 136. Mikart Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 137. Mikart Non-sterile Liquid Product Portfolios and Specifications
Table 138. Mikart Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Mikart Main Business
Table 140. Mikart Latest Developments
Table 141. PharmaVision Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 142. PharmaVision Non-sterile Liquid Product Portfolios and Specifications
Table 143. PharmaVision Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. PharmaVision Main Business
Table 145. PharmaVision Latest Developments
Table 146. Pierre Fabre Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 147. Pierre Fabre Non-sterile Liquid Product Portfolios and Specifications
Table 148. Pierre Fabre Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Pierre Fabre Main Business
Table 150. Pierre Fabre Latest Developments
Table 151. TriRx Pharmaceutical Services Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 152. TriRx Pharmaceutical Services Non-sterile Liquid Product Portfolios and Specifications
Table 153. TriRx Pharmaceutical Services Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. TriRx Pharmaceutical Services Main Business
Table 155. TriRx Pharmaceutical Services Latest Developments
Table 156. UI Pharmaceuticals Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 157. UI Pharmaceuticals Non-sterile Liquid Product Portfolios and Specifications
Table 158. UI Pharmaceuticals Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 159. UI Pharmaceuticals Main Business
Table 160. UI Pharmaceuticals Latest Developments
Table 161. Wasdell Group Basic Information, Non-sterile Liquid Manufacturing Base, Sales Area and Its Competitors
Table 162. Wasdell Group Non-sterile Liquid Product Portfolios and Specifications
Table 163. Wasdell Group Non-sterile Liquid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 164. Wasdell Group Main Business
Table 165. Wasdell Group Latest Developments
List of Figures
Figure 1. Picture of Non-sterile Liquid
Figure 2. Non-sterile Liquid Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-sterile Liquid Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Non-sterile Liquid Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-sterile Liquid Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Solution
Figure 10. Product Picture of Suspension
Figure 11. Product Picture of Gel
Figure 12. Product Picture of Syrup
Figure 13. Product Picture of Ethanolic Liquid
Figure 14. Global Non-sterile Liquid Sales Market Share by Type in 2022
Figure 15. Global Non-sterile Liquid Revenue Market Share by Type (2018-2023)
Figure 16. Non-sterile Liquid Consumed in Human Medication
Figure 17. Global Non-sterile Liquid Market: Human Medication (2018-2023) & (K Units)
Figure 18. Non-sterile Liquid Consumed in Nutraceuticals
Figure 19. Global Non-sterile Liquid Market: Nutraceuticals (2018-2023) & (K Units)
Figure 20. Non-sterile Liquid Consumed in Cosmetics
Figure 21. Global Non-sterile Liquid Market: Cosmetics (2018-2023) & (K Units)
Figure 22. Non-sterile Liquid Consumed in Medical Devices
Figure 23. Global Non-sterile Liquid Market: Medical Devices (2018-2023) & (K Units)
Figure 24. Global Non-sterile Liquid Sales Market Share by Application (2022)
Figure 25. Global Non-sterile Liquid Revenue Market Share by Application in 2022
Figure 26. Non-sterile Liquid Sales Market by Company in 2022 (K Units)
Figure 27. Global Non-sterile Liquid Sales Market Share by Company in 2022
Figure 28. Non-sterile Liquid Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Non-sterile Liquid Revenue Market Share by Company in 2022
Figure 30. Global Non-sterile Liquid Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Non-sterile Liquid Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Non-sterile Liquid Sales 2018-2023 (K Units)
Figure 33. Americas Non-sterile Liquid Revenue 2018-2023 ($ Millions)
Figure 34. APAC Non-sterile Liquid Sales 2018-2023 (K Units)
Figure 35. APAC Non-sterile Liquid Revenue 2018-2023 ($ Millions)
Figure 36. Europe Non-sterile Liquid Sales 2018-2023 (K Units)
Figure 37. Europe Non-sterile Liquid Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Non-sterile Liquid Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Non-sterile Liquid Revenue 2018-2023 ($ Millions)
Figure 40. Americas Non-sterile Liquid Sales Market Share by Country in 2022
Figure 41. Americas Non-sterile Liquid Revenue Market Share by Country in 2022
Figure 42. Americas Non-sterile Liquid Sales Market Share by Type (2018-2023)
Figure 43. Americas Non-sterile Liquid Sales Market Share by Application (2018-2023)
Figure 44. United States Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Non-sterile Liquid Sales Market Share by Region in 2022
Figure 49. APAC Non-sterile Liquid Revenue Market Share by Regions in 2022
Figure 50. APAC Non-sterile Liquid Sales Market Share by Type (2018-2023)
Figure 51. APAC Non-sterile Liquid Sales Market Share by Application (2018-2023)
Figure 52. China Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Non-sterile Liquid Sales Market Share by Country in 2022
Figure 60. Europe Non-sterile Liquid Revenue Market Share by Country in 2022
Figure 61. Europe Non-sterile Liquid Sales Market Share by Type (2018-2023)
Figure 62. Europe Non-sterile Liquid Sales Market Share by Application (2018-2023)
Figure 63. Germany Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Non-sterile Liquid Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Non-sterile Liquid Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Non-sterile Liquid Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Non-sterile Liquid Sales Market Share by Application (2018-2023)
Figure 72. Egypt Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Non-sterile Liquid Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Non-sterile Liquid in 2022
Figure 78. Manufacturing Process Analysis of Non-sterile Liquid
Figure 79. Industry Chain Structure of Non-sterile Liquid
Figure 80. Channels of Distribution
Figure 81. Global Non-sterile Liquid Sales Market Forecast by Region (2024-2029)
Figure 82. Global Non-sterile Liquid Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Non-sterile Liquid Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Non-sterile Liquid Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Non-sterile Liquid Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Non-sterile Liquid Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の非滅菌液体市場予測 2023年-2029年] (コード：LP23DC11840)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非滅菌液体市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の滅菌自己無効化ワクチン注射器市場予測 2023年-2029年
  • 世界の滅菌処理アイソレータ市場予測 2023年-2029年
  • 世界の滅菌使い捨てアセンブリ市場予測 2023年-2029年
  • 世界の滅菌PETG培地ボトル市場予測 2023年-2029年
  • 世界の無菌手術用トレイ市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆